<DOC>
	<DOCNO>NCT02871895</DOCNO>
	<brief_summary>In 2004 , Surviving Sepsis Campaign ( SSC ) introduce guideline management severe sepsis septic shock , well strategy bedside implementation . The treatment recommendation organize two bundle . In international study , enrol adult patient severe sepsis admit intensive care unit , investigator find mortality severe sepsis high ( 44.5 % ) , compliance resuscitation management bundle generally poor much Asia . Investigators need identify patient risk high in-hospital mortality order take appropriate step . From past study , investigator find sepsis involved inflammation coagulation . The multiple organ involvement associate interaction novel biomarkers cytokine . There limited data regard compare application biomarkers different characteristic sepsis treatment . A simultaneous detection multiple cytokine may provide significant prognostic information . For biomarkers , promise observation data put forward , potential need evaluate large-scale , well-designed prospective intervention study clinical use recommend . Besides many clinical study biomarkers confound lack standard bundle care severe sepsis patient . Here investigator perform systematic study aim evaluate 1. individual combine diagnostic accuracy biomarkers predict mortality ; 2. whether trend change biomarker level useful prediction ; 3. biomarker biomarker combination check predict patient risk evolve severe organ dysfunction .</brief_summary>
	<brief_title>Application Biomarkers Change Predict Outcome Patient With Severe Sepsis</brief_title>
	<detailed_description>Variables test association outcome use Pearson chi-square test categorical data Mann-Whitney U test numerical data . Comparison different group conduct use Mann-Whitney U test numerical data use Pearson chi-square test categorical data . The time course biomarker plasma level assess analysis variance . Multivariate analysis perform use logistic regression model estimate odds ratio organ failure dying , along 95 % confidence interval ( CI ) . Forward backward selection procedure use iteratively select variable potentially relate death . Discrimination assess use area receiver operate characteristic curve evaluate well model distinguish patient live die whether progression organ dysfunction . A survival analysis perform use Kaplan-Meier curve log-rank test . Analyses complete two-tailed p &lt; 0.05 consider significant .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Severe sepsis Septic shock Patients &lt; 18 yr Patients immunocompromised ( treatment corticosteroid &gt; 1 mg/kg equivalent prednisone ) Bone marrow organ transplant recipient , Leucopenia [ white blood cell count &lt; 109/L ] neutropenia [ polymorphonuclear granulocyte count &lt; 0.5 109/L ] Hematologic malignancy Acquired immune deficiency syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>sepsis</keyword>
	<keyword>severe sepsis</keyword>
	<keyword>septic shock</keyword>
	<keyword>multiple organ failure</keyword>
</DOC>